Biblio

Export 1713 results:
Author Title Type [ Year(Desc)]
Filters: First Letter Of Last Name is C  [Clear All Filters]
2025
J. D. Melgarejo, Patil, D., Charisis, S., Vatcheva, K. P., Mejia-Arango, S., Mena, L. J., Satizabal, C. L., Gaona, C., Silva, E., Manusov, E., Lee, J. H., Terwilliger, J. D., Gutierrez, J., Seshadri, S., and Maestre, G. E., “Baseline associations of office and ambulatory blood pressure monitoring with cognitive function and dementia prevalence.”, J Alzheimers Dis, p. 13872877251322400, 2025.
D. Mo, Li, X., He, J., Lin, X., Wang, P., Zeng, Y., Wu, X., Liu, L. Y., Chi, L., and Luo, M., “Chronic gingivitis increases the risk of early-onset Alzheimer's disease.”, J Alzheimers Dis, p. 13872877251336259, 2025.
A. Magno Tran Cordeiro, Singulani, M. Patricio, Talib, L. Leme, and Forlenza, O. Vicente, “Down syndrome and Alzheimer's disease: Oxidative stress in the neurodegenerative process.”, J Alzheimers Dis, p. 13872877251326291, 2025.
L. Er Simmatis, Russo, E. E., Steininger, T., Riddell, H., Chen, E., Chiu, Q., Lin, M., Oh, D., Taheri, P., Harmsen, I. E., and Samuel, N., “EEG biomarkers for Alzheimer's disease: A novel automated pipeline for detecting and monitoring disease progression.”, J Alzheimers Dis, p. 13872877251327754, 2025.
L. Er Simmatis, Russo, E. E., Steininger, T., Riddell, H., Chen, E., Chiu, Q., Lin, M., Oh, D., Taheri, P., Harmsen, I. E., and Samuel, N., “EEG biomarkers for Alzheimer's disease: A novel automated pipeline for detecting and monitoring disease progression.”, J Alzheimers Dis, p. 13872877251327754, 2025.
P. S. Crooke, Tossberg, J. T., and Aune, T. M., “Increased unedited Alu RNA patterns found in cortex extracellular vesicles in Alzheimer's disease resemble hippocampus vasculature Alu RNA editing patterns but not cortex Alu RNA editing patterns.”, J Alzheimers Dis, p. 13872877241313054, 2025.
Y. - H. Yang, Chang, H. - W., Chien, C. - F., and Hour, T. - C., “Investigating the effects of 40 Hz sound stimulation on Alzheimer's disease pathways: Modulation of amyloid-β42 secretion, tau phosphorylation, phagocytosis, and autophagy.”, J Alzheimers Dis, p. 13872877251339774, 2025.
Y. - H. Yang, Chang, H. - W., Chien, C. - F., and Hour, T. - C., “Investigating the effects of 40 Hz sound stimulation on Alzheimer's disease pathways: Modulation of amyloid-β42 secretion, tau phosphorylation, phagocytosis, and autophagy.”, J Alzheimers Dis, p. 13872877251339774, 2025.
M. A. Thorwald, Maria, N. S. Sta, Chakhoyan, A., O'Day, P. A., Jacobs, R. E., Zlokovic, B., and Finch, C. E., “Iron chelation by oral deferoxamine treatment decreased brain iron and iron signaling proteins.”, J Alzheimers Dis, p. 13872877241313031, 2025.
E. L. Thacker, Karki, R., Gabor, R., Blades, N. J., Sawyer, R. P., Beckodro, C. N. Kouambo, Preece, Q., Prince, S., Smith, M. K. M., Gillett, S. R., Judd, S. E., Kennedy, R. E., Kizer, J. R., Levine, D. A., McClellan, W. M., Tamura, M. Kurella, Unverzagt, F. W., Wadley, V. G., and Cushman, M., “Leptin, adiponectin, body mass index, and incident cognitive impairment.”, J Alzheimers Dis, p. 13872877251326060, 2025.
P. Grau-Jurado, Mostafaei, S., Xu, H., Mo, M., Petek, B., Kalar, I., Naia, L., Kele, J., Maioli, S., Pereira, J. B., Eriksdotter, M., Chatterjee, S., and Garcia-Ptacek, S., “Medications and cognitive decline in Alzheimer's disease: Cohort cluster analysis of 15,428 patients.”, J Alzheimers Dis, p. 13872877241307870, 2025.
J. A. Luchsinger, Teresi, J. A., Valdez, L., Rosario, D., de Miguel, M., Taylor, D., Singer, J., Chang, N., Fuller, W. S., Boquín, C., Silver, S., Eimicke, J. P., Kong, J., Goldberg, T. E., and Devanand, D. P., “Performance of a smell identification test versus the Mini-Mental Status Exam for the detection of dementia and cognitive impairment among persons with cognitive concerns in primary care.”, J Alzheimers Dis, p. 13872877251345083, 2025.
C. Hyun Park, Lee, H., Lee, Y. - M., Lee, B. - D., Moon, E., Suh, H., Kim, K., Kim, H. - J., Shim, H., Pak, K., Choi, K. - U., and Kim, C. - S., “Sex-specific effects of apolipoprotein E ε4 genotype on longitudinal hippocampal atrophy in amnestic mild cognitive impairment over a 2-year evaluation period.”, J Alzheimers Dis, p. 13872877241313066, 2025.

Pages